Terrie Curran, President and Chief Executive at Phathom Pharmaceuticals, Inc. (PHAT), sold 5,821 shares at $8.20 ($48K) on 2023-01-20, disclosed to the SEC on 2023-01-20.
Open-market sale of $48k PHAT by President and Chief Executive. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PHAT | SELL | 2025-01-23 | $252K | — | Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |